Evofem Biosciences (EVFM) Stock Statistics & Valuation Metrics

Evofem Biosciences has a market cap or net worth of $1.72M. The enterprise value is $52.48M.

Evofem Biosciences has 118,656,360 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evofem Biosciences’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 71.75%.

The current PE Ratio of Evofem Biosciences is ―. Evofem Biosciences’s PEG ratio is ―.

In the last 12 months, Evofem Biosciences had revenue of 19.36M and earned -8.86M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -5.23M and capital expenditures -2.00K, giving a free cash flow of -5.23M billion.

Evofem Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Evofem Biosciences upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).

Evofem Biosciences as a current ratio of 0.17, with Debt / Equity ratio of -65.71%

In the past 12 months, Evofem Biosciences has paid 0.00 in taxes.

Evofem Biosciences EV to EBITDA ratio is -6.67, with an EV/FCF ratio of -11.84.

Evofem Biosciences has $748.00K in cash and marketable securities with $45.73M in debt, giving a net cash position of -$46.56M billion.

Gross margin is 78.83%, with operating margin of -39.64%, and net profit margin of -45.76%.

The average price target for Evofem Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell